VENETOCLAX
Manner of administration:Oral
Restriction
Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Dose modification
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 7 | # of repeats: 0 | DPMQ: $244.79 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Venclexta | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 28 | # of repeats: 2 | DPMQ: $952.80 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Venclexta | |||||